HM Government. No Health without Mental Health: Delivering Better Mental Health Outcomes for People of All Ages. Department of Health, 2011.
Physical health disparities and mental illness: the scandal of premature mortality. Br J Psychiatry
2011; 199: 441–2.
McCreadie, RG. Diet, smoking and cardiovascular risk in people with schizophrenia. Descriptive study. Br J Psychiatry
2003; 183: 534–9.
Newcomer, J, Hennekens, JH. Severe mental illness and risk of cardiovascular disease. JAMA
2007; 298: 1794–6.
Leucht, S, Corves, C, Arbter, D, Engel, RR, Li, C, Davis, JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet
2009; 373: 31–41.
Tiihonen, J, Lönnqvist, J, Wahlbeck, K, Klaukka, T, Niskanen, L, Tanskanen, A, et al. No mental health without physical health. Lancet
2011; 377: 611.
Saha, S, Chant, D, McGrath, J.
A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?
Arch Gen Psychiatry
2007; 64: 1123–31.
Manderbacka, K, Arffman, M, Sund, R, Haukka, J, Keskimäki, I, Wahlbeck, K.
How does a history of psychiatric hospital care influence access to coronary care: a cohort study. BMJ Open
2012; 2: e000831.
Mitchell, AJ, Malone, D, Doebbeling, CC. Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies. Br J Psychiatry
2009; 194: 491–9.
Ryan, MC, Collins, P, Thakore, JH. Impaired fasting glucose and elevation of cortisol in drug-naïve first-episode schizophrenia. Am J Psychiatry
2003; 160: 284–9.
Correll, CU, Manu, P, Olshanskiy, V, Napolitano, B, Kane, JM, Malhotra, AK. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA
2009; 302: 1765–73.
Foley, D, Morley, KI. Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis. Arch Gen Psychiatry
2011; 68: 609–16.
Curtis, J, Henry, C, Watkins, A, Newall, H, Samaras, K, Ward, P.
Metabolic abnormalities in an early psychosis service: a retrospective, naturalistic cross-sectional study. Early Interv Psychiatry
2011; 5: 108–14.
McIntyre, RS, McCann, SM, Kennedy, SH. Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities. Can J Psychiatry
2001; 46: 273–81.
Weiss, R, Dziura, J, Burgert, TS, Tamborlane, WV, Taksali, SE, Yeckel, CW. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med
2004; 350: 2362–74.
Baker, JL, Olsen, LW, Sørensen, TI. Childhood bodymass index and the risk of coronary heart disease in adulthood. N Engl J Med
2007; 357: 2329–37.
Kahn, RS, Fleischhacker, WW, Boter, H, Davidson, M, Vergouwe, Y, Keet, IP, et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet
2007; 371: 1085–97.
Nasrallah, HA. Folie en masse! It's so tempting to drink the Kool-Aid. Curr Psychiatry
2011; 10: 3.
Alvarez-Jimenez, M, Gonzalez-Blanch, C, Crespo-Facorro, B, Hetrick, SE, Rodríguez-Sánchez, JM, Pérez-Iglesias, R, et al. Antipsychotic-induced weight gain in chronic and first episode psychotic disorders – a systematic critical reappraisal. CNS Drugs
2008; 22: 547–62.
Lieberman, JA, Stroup, TS, McEvoy, JP, Swartz, MS, Rosenheck, RA, Perkins, DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med
2005; 353: 1209–23.
Vancampfort, D, Probst, M, Sweers, K, Maurissen, K, Knapen, J, De Hert, M.
Relationships between obesity, functional exercise capacity, physical activity participation and physical self-perception in people with schizophrenia. Acta Psychiatr Scand
2011; 123: 423–30.
Fedorowicz, VJ, Fombonne, E.
Metabolic side effects of atypical antipsychotics in children: a literature review. J Psychopharmacol
2005; 19: 533–50.
Hack, S, Chow, B.
Paediatric psychotropic medication compliance: a literature review and research-based suggestions for improving treatment compliance. J Adolesc Psychopharmacol
2001; 11: 59–67.
Yates, T, Davies, MJ, Khunti, K.
Obesity and chronic disease in younger people: an unfolding crisis. Br J Gen Pract
2012; 62: 4–5.
Joint Health Surveys Unit of the National Centre for Social Research, Department of Epidemiology and Public Health University College London Medical School. Health Survey for England -2009: Health and Lifestyles. NSH Information Centre, 2010 (http://www.ic.nhs.uk/pubs/hse09report).
Wilmot, EG, Davies, MJ, Yates, T, Benhalima, K, Lawrence, IG, Khunti, K.
Type 2 diabetes in younger adults: the emerging UK epidemic. Postgrad Med J
2010; 86: 711–8.
Hillier, TA, Pedula, KL. Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth. Diab Care
2003; 26: 2999–3005.
Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed)
1981; 282: 1847–51.
Curtis, J, Newall, H, Samaras, K.
The heart of the matter: cardiometabolic care in youth with psychosis. Early Interv Psychiatry
2012; 6: 347–53.
Álvarez-Jiménez, M, Hetrick, SE, González-Blanch, C, Gleeson, JF, McGorry, PD. Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry
2008; 193: 101–7.
Doing my best: poverty and self-care among individuals with schizophrenia and diabetes mellitus. Arch Psychiatr Nurs
2007; 21: 49–60.
Cimo, A, Stergiopoulos, E, Cheng, C, Bonato, S, Dewa, C.
Effective lifestyle interventions to improve type II diabetes self-management for those with schizophrenia or schizoaffective disorder: a systematic review. BMC Psychiatry
2012; 12: 24.
Holt, RI, Abdelrahman, T, Hirsch, M, Dhesi, Z, George, T, Blincoe, T, et al. The prevalence of undiagnosed metabolic abnormalities in people with serious mental illness. J Psychopharmacol
2010; 24: 867–73.
Weiden, PJ. Switching antipsychotic medications: not enough, too often, or just right?
Am J Psychiatry
2011; 168: 9.
Morrison, AP, Hutton, P, Shiers, D, Turkington, D.
Antipsychotics: is it time to introduce patient choice?
Br J Psychiatry
2012; 201: 83–4.
Morrison, AP, Hutton, P, Wardle, M, Spencer, H, Barratt, S, Brabban, A, et al. Cognitive therapy for people with a schizophrenia spectrum diagnosis not taking antipsychotic medication: an exploratory trial. Psychol Med
2012; 42: 1049–56.
Fulford, KW. Bringing together values-based and evidence-based medicine: UK Department of Health initiatives in the 'personalization' of care. J Eval Clin Pract
2011; 17: 341–3.
Newall, H, Myles, N, Ward, P, Samaras, K, Shiers, D, Curtis, J.
Efficacy of metformin for prevention of weight gain in psychiatric populations: a review. Int Clin Psychopharmacol
2012; 27: 69–75.
National Institute for Health and Clinical Excellence. Preventing Type 2 Diabetes – Risk Identification and Interventions for Individuals at High Risk. NICE, 2012.
Lester, H, Shiers, DE, Rafi, I, Cooper, SJ, Holt, RIG. Positive Cardiometabolic Health Resource: An Intervention Framework for Patients with Psychosis on Antipsychotic Medication. Royal College of Psychiatrists Centre for Quality Improvement, 2012, in press.